Catalyst Wire Dossier Catalyst Wire Dossier

AMG 334

erenumab · Amgen
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AMG 334, covering 2019-03-13 to 2024-03-28. Get the full timeline:

Most recent: Clinical Trial Update: AMG 334 20160172 Pediatric Migraine PK Study. [Phase 1]

See pricing